A Comprehensive Review of Urinary Tract Infections: Pathogenesis, Resistance, Diagnostics, And the Future of Management

Urinary Tract Infections (UTIs) remain a significant health problem that extends across the globe. They not only cause discomfort to the patients and double the health system cost, but also implicate the issue of antibiotic resistance. Escherichia coli Pathogenic for the urinary tract (UPEC) is referred to as the leading cause of infections. To attach themselves to the urinary tract, penetrate the host cells, as well as secrete antibiotic-resistant biofilms, they are reported to have employed adhesins, toxins, and siderophores. MDR (Multidrug-Resistant) strains have reached a very high level very quickly, especially the case of Extended-Spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae, which has almost resulted in the total extinction of the use of conventional antibiotics. Therefore, the requirement for updated treatment regimens has become necessary. The authors not only examine the molecular UPEC-host as well as the worldwide factors related to the epidemiology and genetic bases of antimicrobial resistance (AMR). On top of traditional culture methods, there are experimental and point-of-care diagnostic tools that are also being developed. Moreover, the authors mark these new options as the following ones: anti-virulence agents, vaccines, bacteriophages, network pharmacology, and molecular docking of natural compounds of Polygonum capitatum. The current accomplishment of UTI therapy is largely attributable to the implementation of combined therapeutic regimens which are the outcome of the union between clinical practice and basic scientific research for better diagnosis, treatment, and prevention.